NDA 020118 · Baxter Hlthcare
Suprane
Desflurane · Inhalation · General Anesthetic
NovelLast checked: Nov 19, 2026Latest source record: Nov 1, 2022 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1992
Sep 18, 1992
Approved uses
2
Original approval plus efficacy supplements
Registered trials
221
12 Phase 3, 12 recruiting
FAERS reports
1,717
1,636 serious, 112 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Jul 15, 2026.
1. INDICATIONS AND USAGE 1.1 Induction of Anesthesia SUPRANE is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. SUPRANE is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. 1.2 Maintenance of Anesthesia SUPRANE is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. After induction of anesthesia with agents other than SUPRANE, and tracheal intubation, SUPRANE is indicated for maintenance of anesthesia in infants and children. SUPRANE is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [See WARNINGS AND PRECAUTIONS (5.3) and CLINICAL STUDIES (14.5)]. Suprane is an inhalation agent indicated: for induction and/or maintenance of anesthesia in adults (1.1) for maintenance of anesthesia in pediatric patients following induction with agents other than Suprane and intubation.
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Dec 15, 2006 Supplement 12 · Efficacy · priority review Pediatric Medical ReviewPediatric Written RequestPediatric Amendment 1
- Sep 18, 1992 Original approval · Type 1 - New Molecular Entity
1 products under this application
- SUPRANE · DESFLURANE 100% · LIQUID, INHALATION · Prescription · TE AN
Clinical trials
Interventional ClinicalTrials.gov studies with "Desflurane" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Volatile Anesthetics to Reduce Mortality in Cardiac SurgeryPivotal-lookingCompleted
Università Vita-Salute San RaffaeleAcademic, hospital or other
NCT02105610 · 5,400 participants · Start Apr 14, 2014 · Primary completion Oct 2017
Drug: desflurane, isoflurane, sevoflurane; total intravenous anesthetics · For: Aortocoronary Bypass; Cardiac Surgery; Coronary Artery Bypass Grafting
Sites: Bahrein, Bahrain; São Paulo, Brazil; Burgas, Bulgaria · 36 sites in all
- Anesthesia and Non-small Cell Lung Cancer RecurrencePivotal-lookingRecruiting
Samsung Medical CenterAcademic, hospital or other
NCT06330038 · 5,384 participants (planned) · Start Aug 5, 2024 · Primary completion Dec 31, 2028
Drug: Propofol; Inhaled anesthetics · For: Non-small Cell Lung Cancer; Surgery; Anesthesia
Sites: Seoul, South Korea
- Desflurane vs. Propofol for Cardiac AnesthesiaPivotal-lookingRecruiting
Xijing HospitalAcademic, hospital or other
NCT07116733 · 3,560 participants (planned) · Start Oct 20, 2025 · Primary completion Dec 31, 2028
Drug: Desflurane group; Propofol group · For: Cardiac Surgery; Coronary Artery Bypass Grafting
Sites: Fuzhou, China; Cangzhou, China; Shijiazhuang, China · 14 sites in all
- General Anesthetics in CAncer REsection Surgery (GA-CARES) TrialPivotal-lookingCompleted
Stony Brook UniversityAcademic, hospital or other
NCT03034096 · 1,826 participants · Start Jan 31, 2017 · Primary completion Sep 30, 2024
Drug: Propofol; Volatile Agent · For: Anesthesia, General; Surgical Oncology
Sites: Buffalo, New York; New Hyde Park, New York; New York, New York · 5 sites in all
- The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative DeliriumPivotal-lookingRecruiting
Medical University of ViennaAcademic, hospital or other
NCT05990790 · 1,332 participants (planned) · Start Sep 3, 2023 · Primary completion Dec 31, 2027
Drug: Desflurane; Sevoflurane and 1 more · For: Postoperative Delirium; Major Noncardiac Surgery; Postoperative Cognitive Dysfunction
Sites: Innsbruck, Austria; Vienna, Austria
- Impact of Desflurane and Sevoflurane on Postoperative Delirium in Elderly PatientsPivotal-lookingStatus unknown
West China HospitalAcademic, hospital or other
NCT06176144 · 890 participants (planned) · Start Sep 10, 2023 · Primary completion Jul 2025
Drug: Desflurane; Sevoflurane · For: Delirium; Postoperative Cognitive Dysfunction
Sites: Chengdu, China
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- hypotension119
- bradycardia103
- cardiac arrest99
- drug interaction97
- anaphylactic shock93
- serotonin syndrome74
- hyperthermia malignant64
- anaphylactic reaction59
- bronchospasm58
- drug ineffective58
- tachycardia57
- foetal exposure during pregnancy48
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 20 |
| 2005 | 37 |
| 2006 | 36 |
| 2007 | 30 |
| 2008 | 57 |
| 2009 | 55 |
| 2010 | 68 |
| 2011 | 66 |
| 2012 | 95 |
| 2013 | 118 |
| 2014 | 105 |
| 2015 | 120 |
| 2016 | 108 |
| 2017 | 116 |
| 2018 | 138 |
| 2019 | 114 |
| 2020 | 84 |
| 2021 | 76 |
| 2022 | 61 |
| 2023 | 65 |
| 2024 | 64 |
| 2025 | 46 |
| 2026 | 37 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Modern inhalational anesthetics for refractory status epilepticus.
Zeiler FA, Zeiler KJ, Teitelbaum J, et al. · Can J Neurol Sci 2015 · Meta-Analysis, Systematic Review
- Propofol prevents further prolongation of QT interval during liver transplantation.
Kim SH, Lee JG, Ju HM, et al. · Sci Rep 2022 · Randomized Controlled Trial
- Coasting: worth the effort?
Hendrickx JF, De Cooman S, Van Zundert AA, et al. · Acta Anaesthesiol Belg 2011 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Effect of different general anaesthetics on ventricular repolarisation in robot-assisted laparoscopic prostatectomy.
Park JH, Lee KY, Choi YD, et al. · Acta Anaesthesiol Scand 2020 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Desflurane analgesia for vaginal delivery.
Abboud TK, Swart F, Zhu J, et al. · Acta Anaesthesiol Scand 1995 · Clinical Trial, Randomized Controlled Trial
- [Prevention and correction of cognitive dysfunction after general anesthesia].
Novikov AY, Kovalev VA, Vinichuk NV, et al. · Zh Nevrol Psikhiatr Im S S Korsakova 2017 · Randomized Controlled Trial
Sponsor: Baxter Hlthcare
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.